Kolexia
Hentzien Maxime
Maladies infectieuses
Hôpital Robert-Debré Reims
Reims, France
145 Activités
337 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Hépatite Co-infection Syndrome d'immunodéficience acquise Diabète Hépatite C Bactériémie Insuffisance rénale chronique

Industries

ViiV Healthcare
19 collaboration(s)
Dernière en 2023
Gilead
5 collaboration(s)
Dernière en 2023
MSD
4 collaboration(s)
Dernière en 2021
VIATRIS MEDICAL
4 collaboration(s)
Dernière en 2022

Dernières activités

Dataids_PEC: Dataids Prospective Observational Cohort on Quality of Care of French HIV Infected Patients
Essai Clinique (DatAids)   26 février 2024
Eosinopenia and routine inflammatory biomarkers are helpful for the diagnosis of infection in patients treated with IL-6 pathway antagonists.
RMD open   09 février 2024
Time Trends in Causes of Death in People with HIV: Insights from the Swiss HIV Cohort Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America   12 janvier 2024
Doravirine plus dolutegravir two-drug regimen as a maintenance ART: Results from a French cohort study
HIV medicine Congress 2023   01 décembre 2023
Idiopathic intracranial hypertension secondary to fluoroquinolone therapy: French pharmacovigilance data review.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology   24 novembre 2023
OPTICOV: OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial: the OPTICOV Study
Essai Clinique (Agence nationale de recherches sur le sida et les hépatites virales)   27 octobre 2023
No Association Between HLA-B*57:01 and Prevalence and/or Outcome of Progressive Multifocal Leukoencephalopathy in a French Nationwide Human Immunodeficiency Virus Cohort.
AIDS research and human retroviruses   18 octobre 2023
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
HIV medicine   24 août 2023
The international Unity study for antivirals against mpox is a blueprint for future epidemics.
Nature medicine   17 août 2023
Country of birth is associated with discrepancies in the prescription of two-drug regimens in successfully treated people with HIV in France.
AIDS (London, England)   13 juillet 2023